What type of study is this?

This is a Literature Review study.

September 10, 2025PharmaceuticsOpen Access

Navigating the Global Regulatory Landscape for Exosome-Based Therapeutics: Challenges, Strategies, and Future Directions

View Full Paper

Ask AI

Bookmark

Authors

NVNagendra Verma SASwati Arora

Discussion

Member takes

Overview

This review analyzes disparities in regulatory frameworks for extracellular vesicle therapeutics, highlighting critical hurdles in quality and safety evaluation.

Key Points

Significant disparities exist between regulatory environments in the United States, EU, and Asia, complicating the translation of EV therapies.
Fragmented regulations create challenges in quality control, safety evaluation, and efficacy demonstration for extracellular vesicle-based interventions.
Regional guidelines must be harmonized to facilitate the successful integration of EV-based therapeutics into clinical practice.
Collaboration among regulatory authorities, industry stakeholders, and academia is essential to ensure patient welfare and product consistency.

Cite This Study

Verma et al. (2025) studied this question.

synapsesocial.com/papers/68c19fa854b1d3bfb60db69b https://doi.org/10.3390/pharmaceutics17080990

View Full Paper

Ask AI

Bookmark

September 10, 2025PharmaceuticsOpen Access

Navigating the Global Regulatory Landscape for Exosome-Based Therapeutics: Challenges, Strategies, and Future Directions

View Full Paper

Ask AI

Bookmark

Authors

NVNagendra Verma SASwati Arora

Discussion

Member takes

Overview

This review analyzes disparities in regulatory frameworks for extracellular vesicle therapeutics, highlighting critical hurdles in quality and safety evaluation.

Key Points

Significant disparities exist between regulatory environments in the United States, EU, and Asia, complicating the translation of EV therapies.
Fragmented regulations create challenges in quality control, safety evaluation, and efficacy demonstration for extracellular vesicle-based interventions.
Regional guidelines must be harmonized to facilitate the successful integration of EV-based therapeutics into clinical practice.
Collaboration among regulatory authorities, industry stakeholders, and academia is essential to ensure patient welfare and product consistency.

Cite This Study

Verma et al. (2025) studied this question.

synapsesocial.com/papers/68c19fa854b1d3bfb60db69b https://doi.org/10.3390/pharmaceutics17080990

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark